Stroke:NEST-2研究,经颅激光治疗对急性缺血性卒中无益

2013-05-30 高晓方 编译 医学论坛网

  美国一项研究表明,经颅激光治疗(TLT)对急性缺血性卒中患者似乎无益。论文于5月9日在线发表于《卒中》(Stroke)。   此项研究(NEST-2)以发病后24小时内接受治疗的急性缺血性卒中患者为受试者,并随机给予TLT或假治疗。在第5天时分别有576和64例患者接受CT和MRI扫描。所有患者均伴有可疑皮质受累。通过总梗塞体积和Alberta卒中项目早期CT评分(ASPECTS)评估TLT

  美国一项研究表明,经颅激光治疗(TLT)对急性缺血性卒中患者似乎无益。论文于5月9日在线发表于《卒中》(Stroke)。

  此项研究(NEST-2)以发病后24小时内接受治疗的急性缺血性卒中患者为受试者,并随机给予TLT或假治疗。在第5天时分别有576和64例患者接受CT和MRI扫描。所有患者均伴有可疑皮质受累。通过总梗塞体积和Alberta卒中项目早期CT评分(ASPECTS)评估TLT对皮质的治疗影响。

  结果显示,总ASPECTS与总梗塞体积强相关,但在总体研究人群中TLT对总梗塞体积、总ASPECTS和相关指标均无影响。在皮质可能受累的各亚组患者中TLT对梗塞体积均无影响。计划纳入1000例患者的NEST-3研究已因患者在90天转归无益而提前终止。该研究的完整结果将于5月31日在欧洲卒中大会上公布。

Transcranial Laser Therapy and Infarct Volume
Background and Purpose
Two randomized trials suggested that transcranial laser therapy (TLT) may benefit patients with acute ischemic stroke, although efficacy has not been confirmed. Supportive proof of concept could be demonstrated if TLT reduces the volume of cortical infarction.
Methods
The NeuroThera Efficacy and Safety Trial-2 (NEST-2) was a randomized trial of TLT versus sham in patients with acute ischemic stroke treated within 24 hours of onset. Infarct volumes were measured quantitatively and semiquantitatively on all protocol-required computed tomography (or MRI, if clinically indicated) scans performed on day 5 (±2). Two approaches assessed treatment effects on cortex: (1) indirectly, by analyzing total infarct volume among patients with clinical presentations suggesting cortical involvement; and (2) directly, by assessing the cortical Alberta Stroke Program Early CT Score (cASPECTS) components (M1-M6, anterior, posterior) on a 0- to 8-point modified scale.
Results
A total of 640 subjects had scans (576 computed tomography, 64 MRI) on day 5. The reliability of ASPECTS (intraclass correlation coefficient=0.85) and cASPECTS (intraclass correlation coefficient=0.82) was excellent, and total ASPECTS was correlated with total infarct volume (r=0.71). In the overall study population, there was no impact of TLT on total infarct volume (P=0.30), total ASPECTS (P=0.85), or cASPECTS (P=0.89). Similarly, no effect was seen in any of the following prespecified subgroups selected to indicate cortical involvement: baseline National Institutes of Health Stroke Scale score >10, Oxfordshire Total Anterior Circulation Syndrome, subjects with aphasia or extinction at baseline, or subjects with radiographic involvement of cortex.
Conclusions
TLT was not associated with a reduction in overall or cortical infarct volume as measured on computed tomography in the subacute phase.

原文阅读:Transcranial laser therapy unhelpful after ischemic stroke
Despite apparently encouraging initial results, transcranial laser therapy (TLT) appears to be of no benefit in patients with acute ischemic stroke.
The conclusions, reported May 9 online in Stroke by Dr. Scott E. Kasner of the University of Pennsylvania in Philadelphia and colleagues, are based on results from NEST-2, a randomized trial of TLT versus sham in patients with acute ischemic stroke treated within 24 hours of onset. That and an earlier trial suggested that the approach might be of benefit...

作者:高晓方 编译



版权声明:
本网站所有注明“来源:梅斯医学”或“来源:MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明“来源:梅斯医学”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言

相关资讯

[ESC 2012]胞磷胆碱对中重度急性缺血性卒中无效

       2012 欧洲卒中大会上,欧洲学者公布的一项研究表明,胞磷胆碱未能有效治疗中重度急性缺血性卒中。研究未能证实本药对急性缺血性卒中有效,这是又一项对潜在的神经保护剂得出阴性结论的研究。论文于2012年6月10日在线发表于《柳叶刀》(Lancet)杂志。[Lancet. 2012 Jun 9.]       &nbs

JAMA:静脉溶栓治疗不增加华法林使用者脑出血风险

       《美国医学会杂志》(JAMA)6月26日发表的一项观察性研究显示,在合用华法林的患者中,静脉应用组织型纤溶酶原激活物(TPA)溶栓治疗急性缺血性卒中不会增加脑出血风险。[JAMA. 2012;307(24):2600-2608.]        这项研究由北卡罗莱纳州杜克临床研究所的Ying Xia

Arch Neurol:阿司匹林抵抗与梗死面积和严重程度相关

    最近一项研究表明阿司匹林抵抗在急性缺血性卒中患者较为常见,并与卒中严重程度及梗死面积增加相关。该研究结果在线发表于11月19日的《神经病学文献》杂志[Arch Neurol 2012 Nov 19;:1-6]。        澳大利亚维多利亚帕克维尔皇家墨尔本医院综合卒中治疗中心的Bernard Yan教授

Neurology:双臂血压差与急性缺血性卒中患者的预后相关

两臂血压差(IAD)值对急性缺血性卒中的预后价值以及它与全身性动脉粥样硬化的相关性尚不清楚。韩国CHA Bundang医学中心的Jinkwon Kim博士等人进行了一项研究,研究结果发表在2013年4月16日的Neurology杂志上。研究结果显示:两臂收缩压或舒张压差值≥10 mm Hg 是急性缺血性卒中的一个强的独立预后标志。 该研究以医院为基础的回顾性观察性研究。研究人员收集急性缺血性卒中